Global Systemic Sclerosis Market accounted for US$ 2.2 billion in 2020 and is estimated to be US$ 3.6 billion by 2030 and is anticipated to register a CAGR of 5.30%. Systemic sclerosis, also known as systemic fibrosis, is an autoimmune rheumatic illness marked by excessive collagen formation and buildup in the skin and internal organs, as well as injury to tiny arteries. Based on the level of skin involvement, there are two broad subtypes of systemic sclerosis: limited and diffuse. With or without facial involvement, the limited form affects areas below, but not above, the elbows and knees. The skin above the elbows and knees is also affected by the diffuse type, which can spread to the torso.

The report " Global Systemic Sclerosis Market, By Drug Class (Immunosuppressors, PDE-5 Inhibitors, Endothelin Receptor Antagonist, Prostacyclin Analogues) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’
Key Highlights:

Kadmon Holdings, Inc. acquired Orphan Medication Designation from the US Food and Drug Administration in September 2020 for its innovative drug candidate, belumosudil (KD025), which is designed to treat systemic sclerosis.
Analyst View:

Researchers and sponsors are concentrating their efforts on rapidly generating new prospective candidates. The kind and method of action of these pipeline products varies. For example, Kadmon Holdings, Inc. acquired Orphan Medication Designation from the US Food and Drug Administration in September 2020 for its innovative drug candidate, belumosudil (KD025), which is designed to treat systemic sclerosis. Belumosudil (KD025) is a Rho-associated coiled-coil kinase 2 inhibitor with a dual mode of action that targets both immunological and fibrotic components. It is currently being tested in a phase 2 clinical trial.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Systemic Sclerosis Market, By Drug Class (Immunosuppressors, PDE-5 Inhibitors, Endothelin Receptor Antagonist, Prostacyclin Analogues) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Systemic-Sclerosis-Market-4775

Key Market Insights from the report:

Global Systemic Sclerosis Market accounted for US$ 2.2billion in 2020 and is estimated to be US$ 3.6 billion by 2030 and is anticipated to register a CAGR of 5.30%. The Global Systemic Sclerosis Market is segmented based on drug type, and region.

Based on Drug Type, Global Systemic Sclerosis Market is segmented into Immunosuppressors, PDE-5 Inhibitors, Endothelin Receptor Antagonist, Prostacyclin Analogues.
By Region, the Global Systemic Sclerosis Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape & their strategies of Global Systemic Sclerosis Market:

The key players operating in the systemic sclerosis market are F. Hoffmann La Roche Ltd.; Johnson & Johnson Services, Inc.; United Therapeutics; Boehringer Ingelheim International GmbH; GlaxoSmithKline plc; Pfizer, Inc.; Eli Lilly and Company; Bayer AG; Mylan N.V.; Teva Pharmaceutical Industries Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]

Website- www.prophecymarketinsights.com